Upregulation of CASC2 increased the cisplatin sensitivity in cisplatin-resistant cervical cancer cells by suppression of miR-21 and upregulation of PTEN and inactivation of pAkt (Feng et al., 2017). The gene discussed is CASC2; the disease is cervical carcinoma.